Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rothenberg

Showing results (601-610 of 658) with videos related to

Pageof 66
Sort By:
The New England Journal of Medicine|October 21, 2020
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and DuodenitisEvan S Dellon, Kathryn A Peterson, Joseph A Murray, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 20, 2016
ESPEN guidelines on definitions and terminology of clinical nutritionT Cederholm, R Barazzoni, P Austin, et al.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
The American Journal of Gastroenterology|December 21, 2021
Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic EsophagitisGirish Hiremath, Lili Sun, Hernan Correa, et al.
Annals of Clinical and Translational Neurology|January 11, 2022
A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALSJonathan S Katz, Jeffrey D Rothstein, Merit E Cudkowicz, et al.
Science Translational Medicine|June 8, 2018
The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responsesNurit P Azouz, Mario A Ynga-Durand, Julie M Caldwell, et al.
Nature Genetics|March 9, 2010
Common variants at 5q22 associate with pediatric eosinophilic esophagitisMarc E Rothenberg, Jonathan M Spergel, Joseph D Sherrill, et al.
Digestive Diseases and Sciences|November 28, 2019
Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal DisordersRobert D Pesek, Craig C Reed, Margaret H Collins, et al.
Biorxiv : the Preprint Server for Biology|June 16, 2021
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cellsMatthew Mahoney, Vishnu C Damalanka, Michael A Tartell, et al.
Pageof 66

Showing results (601-610 of 658) with videos related to

Sort By:
Pageof 66
The New England Journal of Medicine|October 21, 2020
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and DuodenitisEvan S Dellon, Kathryn A Peterson, Joseph A Murray, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 20, 2016
ESPEN guidelines on definitions and terminology of clinical nutritionT Cederholm, R Barazzoni, P Austin, et al.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
The American Journal of Gastroenterology|December 21, 2021
Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic EsophagitisGirish Hiremath, Lili Sun, Hernan Correa, et al.
Annals of Clinical and Translational Neurology|January 11, 2022
A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALSJonathan S Katz, Jeffrey D Rothstein, Merit E Cudkowicz, et al.
Science Translational Medicine|June 8, 2018
The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responsesNurit P Azouz, Mario A Ynga-Durand, Julie M Caldwell, et al.
Nature Genetics|March 9, 2010
Common variants at 5q22 associate with pediatric eosinophilic esophagitisMarc E Rothenberg, Jonathan M Spergel, Joseph D Sherrill, et al.
Digestive Diseases and Sciences|November 28, 2019
Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal DisordersRobert D Pesek, Craig C Reed, Margaret H Collins, et al.
Biorxiv : the Preprint Server for Biology|June 16, 2021
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cellsMatthew Mahoney, Vishnu C Damalanka, Michael A Tartell, et al.
Pageof 66